Literature DB >> 30498317

Pattern of antimicrobial resistance of Gram-negative bacilli in surgical site infections in in-patients and out-patients at an apex trauma Center: 2013-2016.

Nidhi Bhardwaj1, Surbhi Khurana1, Minu Kumari2, Rajesh Malhotra3, Purva Mathur1.   

Abstract

INTRODUCTION: Antimicrobial resistance is an increasing problem worldwide especially among the surgical site infections (SSIs). SSI is becoming more serious due to hospital-acquired infections/nosocomial infections, which further leads to the overuse of broad-spectrum antibiotics. To investigate the antimicrobial resistance patterns among Gram-negative bacteria in SSI in in- and out-patients the present study was designed.
METHODOLOGY: During the 4 years (January 2013-December 2016), the antimicrobial resistant pattern was studied in the admitted patients and in the patients who were followed up to the outpatients department (OPD) after discharge. Antimicrobial resistance pattern testing was done by the disk diffusion method on Mueller-Hinton agar and by E-test for ten antibiotics according to The Clinical and Laboratory Standards Institute guidelines for Gram-negative bacilli.
RESULTS: A total of 2,447 strains were isolated from the studied population on over the period of 4 years. Of 2447, 1996 (81%) were isolated from patients who had SSI during the hospital stay, and 451 (18%) were from patients who attended the OPD after discharge. In the outpatients, who followed up in the OPD for the SSI, Escherichia coli (148), and Pseudomonas aeruginosa (93), whereas in the patients who develop SSI during their hospital stay, Acinetobacter baumannii (622), E. coli (424), and Klebsiella pneumoniae (315) were found to be common. A very high resistance pattern was observed in both the studied groups; however, a higher resistance pattern was seen in in-patients as compared to outpatients.
CONCLUSION: In our study, we have reported resistance pattern in Gram-negative bacteria isolated from the patients who were came for the follow as well as in the inpatients. For the outpatients, it can be concluded that it could be a community-acquired infection which is also an alarming condition for our society.

Entities:  

Keywords:  Antimicrobial resistant; in- and out-patients; surgical site infections

Year:  2018        PMID: 30498317      PMCID: PMC6210838          DOI: 10.4103/JLP.JLP_80_18

Source DB:  PubMed          Journal:  J Lab Physicians        ISSN: 0974-2727


Introduction

Antimicrobial resistance is an increasing problem worldwide especially among the surgical site infections (SSIs). SSI is becoming more serious due to hospital-acquired infections/nosocomial infections.[12] Hospital-acquired infections are increasing day-by-day because of the severity of illness, length of Intensive Care Unit (ICU) stay, and usage of invasive devices and procedures.[345] These infections have been reported to affect approximately 2 million hospitalized patients in the US annually and have imposed 57.6 billion dollars in expense to the US health system in 2000.[467] Patients after surgery are at risk of acquiring hospital-acquired infections which further contributes to higher rates of surgical site rates. A large number of nosocomial infection leads to SSI. SSIs further results in the overuse of broad-spectrum antibiotics. Frequent rational use of these antibiotics results in the resistant to antimicrobial drugs among which high resistant are seen in Gram-negative bacteria. The resistance further leads to serious infections among which SSIs are the most common.[8] Antimicrobial resistance is spreading rapidly among the bacterial population which further made the treatment difficult and challenging especially in surgical and clinical practice.[9] SSI are still remains the major problem in clinical practices and further considering the high level of resistance pattern in SSI patients,[110] it is becoming important to identify the resistant pattern among these SSI cases. Most of the studies were evaluated the resistance pattern of the organisms in SSI cases till the hospital stay only but as most of the infections emerges after the discharge which could be community acquired once the patient was discharged from the hospital. It is very important to establish a resistance pattern of SSI in hospital-acquired or community-acquired infections. To keep this in mind, the present study was designed to investigate the antimicrobial resistance patterns among Gram-negative bacteria in SSIs in in- and out-patients.

Case History

During a 4-year study, from January 2013 to December 2016, we studied pattern of antimicrobial resistance in SSI from outpatients and inpatients, received in the clinical microbiology laboratories.

Bacterial isolates

The Gram-negative bacilli in this study were recovered from clinical samples of SSI from our hospital and patients population was divided into two groups: in- and out-patients.

Inpatients

Gram-negative bacilli were isolated from the patients who develop SSI after the surgery and Pus/wound sample was collected from the surgical site.

Outpatients

Patients after surgery were followed up after discharge, and sample was collected when patients attended the OPD for follow-up. Gram-negative isolates were identified by standard microbiological methods. The identification was confirmed for all isolates by the Vitek 2 identification cards (Biomerix, France). All the strains were stocked at −70°C for further analysis in stocking beads (Microbank, Pro-Lab Diagnostics, and Richmond Hill, Canada).

Antimicrobial susceptibility testing

The antimicrobial susceptibility testing of Gram-negative was performed by the disk diffusion method on Mueller-Hinton agar according to the recommendations of the Clinical and Laboratory Standards Institute (CLSI). The following antibiotics were tested: Amikacin (AMK) (30 μg), Cefepime (CFPM) (30 μg), Cefoperazone/Sulbactam (CPZ/SUL) (75/30 μg), Ceftazidime (CAZ) (30 μg), Chloramphenicol (CAM) (30 μg), Ciprofloxacin (CIP) (5 μg), Imipenem (IPM) (10 μg), Netilmycin (NET) (30 μg), Piperacillin/Tazobactam (PIT) (100 μg/10 μg), and Tigecycline (TGC) (15 μg). The MIC was determined by E-test for all the above antimicrobials; performed according to manufacturer's recommendations (Biomeriux Ltd., formerly AB Biodisk, Sweden). The inhibition zone diameters and MIC breakpoints were adopted according to CLSI guidelines for Gram-negative bacilli.

Results

A total of 2447 strains were isolated from the studied population over the period of 4 years. Of 2447, 1996 (81%) were isolated from patients who had SSI during the hospital stay, and 451 (18%) were from patients who attended the outpatients department (OPD) after discharge. In the outpatients, who followed up in the OPD for the SSI, Escherichia coli (148) and Pseudomonas aeruginosa (93) were observed to be the most common isolate followed by Klebsiella pneumoniae (58), Acinetobacter baumannii (49), Enterobacter cloacae (42), and Proteus mirabilis (40), whereas in the patients who develop SSI during their hospital stay, A. baumannii (622), E. coli (424) and K. pneumoniae (315) were found to be commonly followed by P. aeruginosa (298), E. cloacae (137) during 2013–2016. All the organisms were isolated from pus and wound. Distribution of Gram-negative organisms during the study period is shown in Table 1.
Table 1

Distribution of organisms over the period of 4 years

Distribution of organisms over the period of 4 years

Antimicrobial Resistance patterns of Gram-negative bacteria in surgical site infections resistance pattern in outpatients

A high level of the resistant pattern was observed in the patients who were followed up for the SSI after discharge. The highest resistance by A. baumannii was seen followed by K. pneumonia, E. coli and P. aeruginosa against AMK, CFPM, CPZ/SUL, CAZ, CAM, CIP, IPM, NET, and PIT. Resistance to TGC was least in all organisms isolated from a sample taken from OPD patients. Only P. aeruginosas showed high resistance in TGC. Among the isolates obtained from the OPD patient A. baumannii, E. cloacae, K. pneumonia, E. coli and P. aeruginosa shown a very high resistance to above-mentioned antibiotics. The detailed resistant pattern of these organisms are shown in Table 2.
Table 2

Antimicrobial resistant pattern of Gram-negative bacteria isolated from surgical site infection of outpatients

Antimicrobial resistant pattern of Gram-negative bacteria isolated from surgical site infection of outpatients

Resistance pattern in inpatients

As compared to the outpatient population, inpatients population showed a high number of organisms isolated from the surgical site and very high resistance was seen in this group of the population. Among the total isolated (1996) obtained from inpatients A. baumannii, Aeromonas hydrophilla, Citrobacter fruendii, E. cloacae, E. coli, K. pneumoniae, Morganella morganii, P. mirabilis, Providencia stuartii, and P. aeruginosa were found to be common isolates and showed high resistance among these organism. A. baumannii showed 97% resistance to CAZ and CFPM (Cefepime); 95% to PIT; 94% and 91% to AMK and CAM, respectively. Similar high resistance by E. coli for CIP (92%) and CAZ (90%); K. pneumoniae showed 88% resistance to CAZ, 85% to CEPM, 81% to NET and CIP; P. aeruginosa showed 89% resistance to CAM. The detailed resistant pattern of these organisms is shown in Table 3.
Table 3

Antimicrobial resistant pattern of Gram-negative bacteria isolated from surgical site infection of inpatients

Antimicrobial resistant pattern of Gram-negative bacteria isolated from surgical site infection of inpatients

Discussion

Antimicrobial resistance in surgical sites is emerging problem worldwide, which further result in increased hospital stay of the patients and mortality. SSI is the most common problem in hospital after surgery further increasing resistance to the antibiotics are of major concern. In the present study, resistance pattern was studied in SSI patients.[8910] A total of 451 isolates were found in the patients who had SSI after discharge, and a very high number of SSI isolates (n = 1996) were reported in the admitted patients. Similarly, we have reported the difference in antibiotic-resistant in SSI group of patients. In the present study, A. baumannii, C. fruendii, E. cloacae, E. coli, K. pneumoniae, P. mirabilis, Providencia stuartii, and P. aeruginosa showed high resistance to most of the antibiotics tested in the study; A. baumannii showed 97% resistance to CAZ and CEPM; 95% to PIT; 94% and 91% to AMK and CAM, respectively whereas in the outpatients Acinetobacter baumannii showed 76% resistance to CAZ and 82% to CEPM; 71% to PIT; 71% and 80% to AMK and CAM, respectively. Similarly, high resistance by E. coli for CIP (92%) and CAZ (90%); K. pneumoniae showed 88% resistance to CAZ, 85% to CEPM, 81% to NET and CIP; P. aeruginosa showed 89% resistance to CAM. Whereas, in outpatients, E. coli for CIP (66%) and CAZ (76%); K. pneumoniae showed 67% resistance to CAZ, 59% to CEPM, 57% to NET, and 60% to CIP; P. aeruginosa showed 74% resistance to CAM. Increasing pattern in antimicrobial drugs are increasing worldwide in a study published in 2016 by published in 2016 by Krunal Shah reported decreased level of IPM from 94.25% to 36.17% over the period of 2½ years, however in contrast to our they have reported increased level of susceptibility in AMK from 29.31% to 40.42%.[11] A study by Chandra Prakash Bhatt in 2014 showed similar results for Gram-negative isolates on SSI, Acinetobacter spp., K. pneumoniae, E. coli, and P. aeruginosa and they have also reported a high level of resistance to the antibiotics tested in the study.[12] They have found 73.91% resistance to CIP, but in contrast, they have found AMK sensitive to Gram-negative bacteria. Raza et al.[12] showed that 96/120 (80%) sample was culture positive out of them 58.33% were Gram-negative bacilli.[13] A very high level of resistance was observed in the admitted patients, especially in ICU patients who are due to nosocomial infection by another study.[14] Antimicrobial resistance pattern for SSI patients for each hospital is important for the appropriate treatment of the patients and to control the nosocomial infection in the hospital setting.

Conclusion

In our study, we have reported resistance pattern in Gram-negative bacteria isolated from the patients who were came for the follow, so it can be concluded that it could be a community-acquired infection which is also an alarming condition for our society. Society needs to control the commercially available antibiotics in the market. Our data suggest the high level of resistance in SSI in- and out-patients. Surveillance of SSI is important to understand the magnitude of the problem and find out appropriate preventive methods.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

1.  Nosocomial infection and fatality in medical and surgical intensive care unit patients.

Authors:  D E Craven; L M Kunches; D A Lichtenberg; N R Kollisch; M A Barry; T C Heeren; W R McCabe
Journal:  Arch Intern Med       Date:  1988-05

2.  Surgical Site Infections and Antimicrobial Resistance Pattern.

Authors:  Raskin Chaudhary; Shrawan Kumar Thapa; Jid Chani Rana; Pradeep Kumar Shah
Journal:  J Nepal Health Res Counc       Date:  2017-09-08

3.  Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015.

Authors:  Yoshio Takesue; Shinya Kusachi; Hiroshige Mikamo; Junko Sato; Akira Watanabe; Hiroshi Kiyota; Satoshi Iwata; Mitsuo Kaku; Hideaki Hanaki; Yoshinobu Sumiyama; Yuko Kitagawa; Toru Mizuguchi; Yoshiyasu Ambo; Masafumi Konosu; Keiichiro Ishibashi; Akihisa Matsuda; Kazuo Hase; Yasushi Harihara; Koji Okabayashi; Shiko Seki; Takuo Hara; Koshi Matsui; Yoichi Matsuo; Minako Kobayashi; Shoji Kubo; Kazuhisa Uchiyama; Junzo Shimizu; Ryohei Kawabata; Hiroki Ohge; Shinji Akagi; Masaaki Oka; Toshiro Wakatsuki; Katsunori Suzuki; Kohji Okamoto; Katsunori Yanagihara
Journal:  J Infect Chemother       Date:  2017-04-05       Impact factor: 2.211

4.  Nosocomial surgical infections: incidence and cost in a developing country.

Authors:  P Prabhakar; D Raje; D Castle; B Rao; P Fletcher; D Duquesnay; S Venugopal; R Carpenter
Journal:  Am J Infect Control       Date:  1983-04       Impact factor: 2.918

5.  Public health focus: surveillance, prevention, and control of nosocomial infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1992-10-23       Impact factor: 17.586

Review 6.  Surgical site infections: epidemiology, microbiology and prevention.

Authors:  C D Owens; K Stoessel
Journal:  J Hosp Infect       Date:  2008-11       Impact factor: 3.926

Review 7.  Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis; Ilias I Siempos
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

8.  Surgical site infection in critically ill patients with secondary and tertiary peritonitis: epidemiology, microbiology and influence in outcomes.

Authors:  Josep Ballus; Juan C Lopez-Delgado; Joan Sabater-Riera; Xose L Perez-Fernandez; A J Betbese; J A Roncal
Journal:  BMC Infect Dis       Date:  2015-07-30       Impact factor: 3.090

9.  Antimicrobial resistance pattern in a tertiary care hospital: An observational study.

Authors:  Revathy Saravanan; Vinod Raveendaran
Journal:  J Basic Clin Pharm       Date:  2013-06
  9 in total
  3 in total

1.  Drug resistance of pathogens causing nosocomial infection in orthopedics from 2012 to 2017: a 6-year retrospective study.

Authors:  Xiaowei Yang; Runsheng Guo; Banglin Xie; Qi Lai; Jiaxiang Xu; Niya Hu; Lijun Wan; Min Dai; Bin Zhang
Journal:  J Orthop Surg Res       Date:  2021-02-01       Impact factor: 2.359

2.  High contribution and impact of resistant gram negative pathogens causing surgical site infections at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.

Authors:  Aiman El-Saed; Hanan H Balkhy; Majid M Alshamrani; Sameera Aljohani; Asim Alsaedi; Wafa Al Nasser; Ayman El Gammal; Saad A Almohrij; Ziyad Alyousef; Sara Almunif; Mohammad Alzahrani
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

Review 3.  Highlighting the gaps in quantifying the economic burden of surgical site infections associated with antimicrobial-resistant bacteria.

Authors:  Katia Iskandar; Massimo Sartelli; Marwan Tabbal; Luca Ansaloni; Gian Luca Baiocchi; Fausto Catena; Federico Coccolini; Mainul Haque; Francesco Maria Labricciosa; Ayad Moghabghab; Leonardo Pagani; Pierre Abi Hanna; Christine Roques; Pascale Salameh; Laurent Molinier
Journal:  World J Emerg Surg       Date:  2019-11-21       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.